10 proof-checking-postdoc-computer-science-logic PhD scholarships at University of Copenhagen
-
The Department of Chemistry invites applicants for a PhD fellowship in computational homogenous catalyst discovery. Start date is 1.9.2025 or as soon as possible thereafter. The project The project
-
Department of Plant and Environmental Sciences invites applicants for a PhD fellowship in Biochars for Environmental Remediation. The project is made available through the Sino-Danish University
-
, Section for Environmental Chemistry and Physics, jch@plen.ku.dk , phone: +4535332456. The PhD programme Depending on your level of education, you can undertake the PhD programme as either: Option A: A
-
of Health and Medical Sciences. The PhD study must be completed in accordance with The Ministerial Order on the PhD programme (2013) and the Faculty’s rules on achieving the degree. The PhD student is
-
We are seeking an outstanding candidate for a PhD fellowship in the field of computational fluid and solid mechanics. The fellowship will start on September 1st, 2025, or as soon as possible after
-
collaboration, as part of the employment process at the University of Copenhagen. Notice: In the following description of the PhD programmes, some references are made to SCIENCE websites The PhD programme
-
The Novo Nordisk Foundation Quantum Computing Programme (NQCP) is establishing a talented and diverse international team to create a cutting-edge quantum programme in the heart of Copenhagen
-
more than 1300 Danish 6-11-year-old children. This included food and nutrition intervention components in the form of a school lunch programme, activities in the local supermarkets and SFO and practical tools
-
www.transition.ku.dk The PhD program is a study program, which aims at training PhD students, at an international level, to undertake research, development, and teaching assignments. These qualifications open a window
-
sciences and advancing vaccine development. NIVI-R conducts scientific research, while NIVI-D works to quickly turn that research into new vaccine candidates. NIVI-D accelerates clinical trials (phases 1 and